Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

11.76
Delayed Data
As of Aug 17
 -0.16 / -1.34%
Today’s Change
8.18
Today|||52-Week Range
15.20
+19.03%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale2/03/20179,085$12.26$111.4K-4.08%
Third Security Llc
Director
Buy5/11/201710,000$10.37$103.7K-15.40%
Matsui Connie L
Director
Buy5/08/201710,000$10.37$103.7K-15.09%
Countouriotis Athena
Chief Medical Officer & Senior Vice President
Sale2/03/20176,900$12.26$84.6K-4.08%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale2/03/20176,198$12.26$76.0K-4.08%
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale6/15/20172,583$13.05$33.7K-9.89%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale4/13/20172,583$12.81$33.1K-8.20%
Third Security Llc
Director
Gift5/04/201714,135$0.00$0.00-16.89%
Countouriotis Athena
Chief Medical Officer & Senior Vice President
Buy1/05/20177,500$0.00$0.00-6.74%
Torley Helen I
President & Chief Executive Officer
Buy1/06/201730,000$0.00$0.00-12.11%
Page of 3